Protecting the Brain From Post-Stroke Cognitive Impairment and Dementia With Multimodal Exercise Training
PROTECT
1 other identifier
interventional
120
1 country
2
Brief Summary
The rates of cognitive decline and dementia after stroke are disproportionately high. Strategies that can protect the brain early after the stroke event could reduce the future risk of cognitive decline and dementia in these patients. Although physical exercise is usually recommended after stroke, there is very little information about the protective effect of exercise implemented in early stages of recovery as a potential protective measure against cognitive decline and dementia risk in these patients. This study will investigate the effect of a multimodal exercise intervention implemented early after the stroke event on cognition and on a selected group of markers that can predict cognitive decline and dementia risk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable stroke
Started Mar 2026
Longer than P75 for not_applicable stroke
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 19, 2026
CompletedFirst Posted
Study publicly available on registry
March 3, 2026
CompletedStudy Start
First participant enrolled
March 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2030
July 6, 2026
June 1, 2026
3.9 years
February 19, 2026
July 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cognition
The primary outcome will be change in cognition immediately post-intervention (T1, primary endpoint) as measured by the ADAS-Cog-13, a 13-item cognitive assessment with scores ranging from 0 to 85, where lower scores indicate better cognition. The minimal clinical importance difference (MCID) on this scale is 2.
Baseline (T0), 12-week post-intervention (T1), follow-up at 6 months (T2) and 12 months (T3)
Secondary Outcomes (8)
Cognition
Baseline (T0), 12-week post-intervention (T1), follow-up at 6 months (T2) and 12 months (T3)
Cerebral Blood Flow
Baseline (T0), 12-week post-intervention (T1), and follow-up at 12 months (T3)
Blood Brain Barrier Permeability
Baseline (T0), 12-week post-intervention (T1), and follow-up at 12 months (T3)
White Matter Structure and Integrity
Baseline (T0), 12-week post-intervention (T1), and follow-up at 12 months (T3)
Cerebral Blood Velocity (Middle Cerebral Artery Velocity)
Baseline (T0), 12-week post-intervention (T1), follow-up at 6 months (T2) and follow-up at 12 months (T3)
- +3 more secondary outcomes
Other Outcomes (10)
Cardiorespiratory Fitness
Baseline (T0), 12-week post-intervention (T1), follow-up at 6 months (T2) and 12 months (T3)
Physical Function
Baseline (T0), 12-week post-intervention (T1), follow-up at 6 (T2) and 12 months (T3)
Functional mobility
Baseline (T0), 12-week post-intervention (T1), follow-up at 6 (T2) and 12 months (T3)
- +7 more other outcomes
Study Arms (2)
Multimodal Exercise
EXPERIMENTALTwelve weeks of combined resistance and aerobic exercise training held three times per week.
Balance, Toning and Stretching
ACTIVE COMPARATORTwelve weeks of low-intensity task-specific strengthening, balance, mobility, and stretching training held three times per week that is based off the Fitness and Mobility Exercise Program.
Interventions
Training sessions, which will include resistance training followed by aerobic exercise training, will start with \~5 minutes of warm-up and end with \~5 minutes of cool down. Resistance training (20-30 minutes) will involve one day of upper limb, one day of lower limb and one day of full body exercises involving major muscle groups. Each session will include 5 exercises for 2-3 sets x 10 repetitions. Workloads will be increased from moderate to vigorous intensities (≥50-85% 1-RM; RPE≥14/20) by adding movement modifications and/or increasing resistance to ensure progressive overload. The first 4 weeks of aerobic exercise will involve 20 minutes of moderate intensity continuous training (40-60% HRR; RPE\<13/20). The following 4 weeks, will involve 3x4 minutes (long-interveral) high intensity interval training (HIIT) at ≥60-80% HRR; RPE=≥14-17. The last 4 weeks will involve 10, 1x1 minutes (short-interval) HIIT at ≥80-100% HRR; RPE≥17/20.
Sessions will be performed at light intensity (\<40% HRR) and finalize with a 5-minute cool-down. During the 40-60 minute session, 5 to 6 exercises (2-3 sets x 10 reps) involving balance, toning and stretching will be performed. Participants will progress through increasingly challenging exercises (e.g., reduce base of support in balance exercises), but they will aim to maintain a HRR \<40%.
Eligibility Criteria
You may qualify if:
- medically stable
- have had a first-ever ischemic/hemorrhagic stroke confirmed by MRI/CT 0-6 months prior to participation.
- Able to independently walk at least 10 meters (assistive devices permitted) and capable of following instructions will be required.
You may not qualify if:
- Diagnosed with dementia
- Medications that impact cognition
- Absolute contraindications to exercise or MRI scanning
- Significant disability (modified Rankin score \>3)
- Participants will be excluded if they have been engaged in a structured exercise training program outside their regular in/out-patient hospital rehabilitation since suffering the stroke.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Montreal Neurological Institute and Hospitalcollaborator
- McGill Universitylead
- Jewish Rehabilitation Hospitalcollaborator
- McMaster Universitycollaborator
- Centre for Interdisciplinary Research in Rehabilitation of Greater Montrealcollaborator
Study Sites (2)
McMaster University
Hamilton, Ontario, L8S 1C7, Canada
Jewish Rehabilitation Hospital
Laval, Quebec, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marc Roig
McGill University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Statistician
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 19, 2026
First Posted
March 3, 2026
Study Start
March 9, 2026
Primary Completion (Estimated)
January 30, 2030
Study Completion (Estimated)
December 31, 2030
Last Updated
July 6, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
Anonymized datasets that are prepared and/or analyzed during the current study will be available in the repository of journals upon publication. We will state in the published articles that data are available upon reasonable request to corresponding author Dr. Marc Roig.